Value of polymerase chain reaction test on amniotic fluid for the prenatal diagnosis of congenital toxoplasmosis;Apport des techniques de biologie moléculaire dans le diagnostic prénatal de la toxoplasmose congénitale

Immuno-Analyse et Biologie Specialisee

Volumn 17, Issue 6, 2002, Pages 358-362

  Bessieres M H ^a   Cassaing, S ^a   Berrebi, A ^b   Seguela J P ^a  

^a CHU RANGUEIL   (France)

^b Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

Congenital toxoplasmosis; Mouse inoculation; PCR; Prenatal diagnosis

Indexed keywords

AMNIOCENTESIS; AMNION FLUID; ANIMAL MODEL; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FETUS; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SEROLOGY; TOXOPLASMA GONDII;

EID: 17144456590     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(02)01224-3     Document Type: Article

References (19)

1. Ancelle T., Goulet V., Tirard-Fleury V., Baril L., Du Mazaubrun C., Thulliez P., Wcislo M., Carme B. La toxoplasmose chez la femme enceinte en France en 1995, Résultats d'une enquête nationale périnatale. B.E.H. 51:1996;227-228.
2. Berrebi A., Kobuch W.E., Bessières M.H., et al. Termination of pregnancy for maternal toxoplasmosis. Lancet. 344:1994;36-39.
3. Bessières M.H., Berrebi A., Rolland M., Bloom M.C., Roques C., Cassaing S., Courjault C., Séguéla J.P. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. European J. Obstetrics & Gynecology and Reproductive Biology. 94:2001;37-45.
4. Cazenave J., Forestier F., Bessières M.H., Broussin B., Begueret J. Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenat. Diagn. 12 (2):Feb, 1992;119-127.
5. Costa J.M., Ernault P., Gautier E., Bretagne S. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat. Diagn. 21 (2):Feb, 2001;85-88.
6. Daffos F., Forestier F., Capella-Pavlovsky M., Thulliez P., Aufrant C., Valenti D., Cox W.L. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N. Engl. J. M. 318 (5):Feb 4, 1988;271-275.
7. Foulon W., Pinon J.M., Stray-Pedersen B., Pollak A., Lappalainen M., Decoster A., Villena J., Jenum P.A., Hayde M., Naessens A. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am. J. Obstet. Gynecol. 181 (4):Oct, 1999;843-847.
8. Forestier F., Daffos F., Rainaut M., et al. Suivi thérapeutique fœtomaternal de la spiramycine en cours de grossesse. Arch. Fr. Pédiatr. 44:1987;539-544.
9. Fricker-Hidalgo H., Pelloux H., Muet F., Racinet F., Bost M., Goullier-Fleuret A., Ambroise-Thomas P. Prenatal diagnosis of congenital toxoplasmosis: comparative value of fetal blood and amniotic fluid using serological techniques and cultures. Prenat. Diagn. 17 (9):Sep, 1997;831-835.
10. Gratzel R., Hayde M., Kohlhauser C., Hermon M., Burda G., Strobl W., Pollak A. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur. J. Clin. Microbiol. Infect. Dis. 17 (12):Dec, 1998;853-858.
11. Hezard N., Marx-Chemla C., Foudrinier F., Villena I., Quereux C., Leroux B., Dupouy D., Talmud M., Pinon J.M. Prenatal diagnosis of congenital toxoplasmosis in 261 pregnancies. Prenat. Diagn. 17 (11):Nov, 1997;1047-1054.
12. Hohlfeld P., Daffos F., Costa J.M., Thulliez P., Forestier F., Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid. N. Engl. J. M. 331 (11):Sep 15, 1994;695-699.
13. Pelloux H., Guy E., Angelici M.C., Aspock H., Bessières M.H., Blatz R., Del Pezzo M., Girault V., Gratzl R., Holberg-Petersen M., Johnson J., Kruger D., Lappalainen M., Naessens A., Olsson M. A second european collaborative study on polymerase chain reaction for Toxoplasma gondii involving 15 teams. FEMS Microbiol. Lett. 165 (2):Aug 151998;231-237.
14. Pratlong F., Boulot P., Villena J., Issert E., Tamby I., Cazenave J., Dedet J.P. Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br. J. Obstet. Gynaecol. 103 (6):Jun, 1996;552-557.
15. Robert-Gangneux F., Gavinet M.F., Ancelle T., Raymond J., Tourte-Schaefer C., Dupouy-Camet J. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J. Clin. Microbiol. 37 (9):Sep, 1999;2893-2898.
16. Romand S., Wallon M., Franck J., Thulliez P., Peyron F., Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet. Gynecol. 97 (2):Feb, 2001;296-300.
17. Schoondermark, Van de Ven E., Galama J., Camps W., Vree T., Russel F., Meuwissen J., Melchers W. Pharmacokinetics of spiramycin in the rhesus monkey:transplacental passage and distribution in tissue in the fetus. Antimicrob. Agents Chemother. 38:1994;1922-1929.
18. Schoondermark, Van de Ven E., Melchers W., Camps W., Eskes T., Meuwissen J., Galama J. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob. Agents Chemother. 38:1994;1930-1936.
19. Villena I., Aubert D., Leroux B., et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow up of 78 cases betwwenand1997. Scand J Infect Dis. 30:(1998):1980;295-300.